Tags

Type your tag names separated by a space and hit enter

Epidemiology and sociodemographics of systemic lupus erythematosus and lupus nephritis among US adults with Medicaid coverage, 2000-2004.
Arthritis Rheum 2013; 65(3):753-63AR

Abstract

OBJECTIVE

Systemic lupus erythematosus (SLE) and lupus nephritis (LN) disproportionately affect individuals who are members of racial/ethnic minority groups and individuals of lower socioeconomic status (SES). This study was undertaken to investigate the epidemiology and sociodemographics of SLE and LN in the low-income US Medicaid population.

METHODS

We utilized Medicaid Analytic eXtract data, with billing claims from 47 states and Washington, DC, for 23.9 million individuals ages 18-65 years who were enrolled in Medicaid for >3 months in 2000-2004. Individuals with SLE (≥3 visits >30 days apart with an International Classification of Diseases, Ninth Revision [ICD-9] code of 710.0) and with LN (≥2 visits with an ICD-9 code for glomerulonephritis, proteinuria, or renal failure) were identified. We calculated SLE and LN prevalence and incidence, stratified by sociodemographic category, and adjusted for number of American College of Rheumatology (ACR) member rheumatologists in the state and SES using a validated composite of US Census variables.

RESULTS

We identified 34,339 individuals with SLE (prevalence 143.7 per 100,000) and 7,388 (21.5%) with LN (prevalence 30.9 per 100,000). SLE prevalence was 6 times higher among women, nearly double in African American compared to white women, and highest in the US South. LN prevalence was higher among all racial/ethnic minority groups compared to whites. The areas with lowest SES had the highest prevalence; areas with the fewest ACR rheumatologists had the lowest prevalence. SLE incidence was 23.2 per 100,000 person-years and LN incidence was 6.9 per 100,000 person-years, with similar sociodemographic trends.

CONCLUSION

In this nationwide Medicaid population, there was sociodemographic variation in SLE and LN prevalence and incidence. Understanding the increased burden of SLE and its complications in this low-income population has implications for resource allocation and access to subspecialty care.

Authors+Show Affiliations

Brigham and Women's Hospital, Boston, Massachusetts 02115, USA. chfeldman@partners.orgNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info available

Pub Type(s)

Journal Article
Research Support, N.I.H., Extramural

Language

eng

PubMed ID

23203603

Citation

Feldman, Candace H., et al. "Epidemiology and Sociodemographics of Systemic Lupus Erythematosus and Lupus Nephritis Among US Adults With Medicaid Coverage, 2000-2004." Arthritis and Rheumatism, vol. 65, no. 3, 2013, pp. 753-63.
Feldman CH, Hiraki LT, Liu J, et al. Epidemiology and sociodemographics of systemic lupus erythematosus and lupus nephritis among US adults with Medicaid coverage, 2000-2004. Arthritis Rheum. 2013;65(3):753-63.
Feldman, C. H., Hiraki, L. T., Liu, J., Fischer, M. A., Solomon, D. H., Alarcón, G. S., ... Costenbader, K. H. (2013). Epidemiology and sociodemographics of systemic lupus erythematosus and lupus nephritis among US adults with Medicaid coverage, 2000-2004. Arthritis and Rheumatism, 65(3), pp. 753-63. doi:10.1002/art.37795.
Feldman CH, et al. Epidemiology and Sociodemographics of Systemic Lupus Erythematosus and Lupus Nephritis Among US Adults With Medicaid Coverage, 2000-2004. Arthritis Rheum. 2013;65(3):753-63. PubMed PMID: 23203603.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Epidemiology and sociodemographics of systemic lupus erythematosus and lupus nephritis among US adults with Medicaid coverage, 2000-2004. AU - Feldman,Candace H, AU - Hiraki,Linda T, AU - Liu,Jun, AU - Fischer,Michael A, AU - Solomon,Daniel H, AU - Alarcón,Graciela S, AU - Winkelmayer,Wolfgang C, AU - Costenbader,Karen H, PY - 2012/07/24/received PY - 2012/11/06/accepted PY - 2012/12/4/entrez PY - 2012/12/4/pubmed PY - 2013/4/25/medline SP - 753 EP - 63 JF - Arthritis and rheumatism JO - Arthritis Rheum. VL - 65 IS - 3 N2 - OBJECTIVE: Systemic lupus erythematosus (SLE) and lupus nephritis (LN) disproportionately affect individuals who are members of racial/ethnic minority groups and individuals of lower socioeconomic status (SES). This study was undertaken to investigate the epidemiology and sociodemographics of SLE and LN in the low-income US Medicaid population. METHODS: We utilized Medicaid Analytic eXtract data, with billing claims from 47 states and Washington, DC, for 23.9 million individuals ages 18-65 years who were enrolled in Medicaid for >3 months in 2000-2004. Individuals with SLE (≥3 visits >30 days apart with an International Classification of Diseases, Ninth Revision [ICD-9] code of 710.0) and with LN (≥2 visits with an ICD-9 code for glomerulonephritis, proteinuria, or renal failure) were identified. We calculated SLE and LN prevalence and incidence, stratified by sociodemographic category, and adjusted for number of American College of Rheumatology (ACR) member rheumatologists in the state and SES using a validated composite of US Census variables. RESULTS: We identified 34,339 individuals with SLE (prevalence 143.7 per 100,000) and 7,388 (21.5%) with LN (prevalence 30.9 per 100,000). SLE prevalence was 6 times higher among women, nearly double in African American compared to white women, and highest in the US South. LN prevalence was higher among all racial/ethnic minority groups compared to whites. The areas with lowest SES had the highest prevalence; areas with the fewest ACR rheumatologists had the lowest prevalence. SLE incidence was 23.2 per 100,000 person-years and LN incidence was 6.9 per 100,000 person-years, with similar sociodemographic trends. CONCLUSION: In this nationwide Medicaid population, there was sociodemographic variation in SLE and LN prevalence and incidence. Understanding the increased burden of SLE and its complications in this low-income population has implications for resource allocation and access to subspecialty care. SN - 1529-0131 UR - https://www.unboundmedicine.com/medline/citation/23203603/Epidemiology_and_sociodemographics_of_systemic_lupus_erythematosus_and_lupus_nephritis_among_US_adults_with_Medicaid_coverage_2000_2004_ L2 - https://doi.org/10.1002/art.37795 DB - PRIME DP - Unbound Medicine ER -